Characterising (18)F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging

BACKGROUND: (18)F-fluciclovine is a synthetic amino acid positron emission tomography (PET) radiotracer that is approved for use in prostate cancer. In this clinical study, we characterised the kinetic model best describing the uptake of (18)F-fluciclovine in breast cancer and assessed differences i...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, N. P., Teoh, E. J., Flight, H., Jones, B. E., Niederer, J., Mustata, L., MacLean, G. M., Roy, P. G., Remoundos, D. D., Snell, C., Liu, C., Gleeson, F. V., Harris, A. L., Lord, S. R., McGowan, D. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854436/
https://www.ncbi.nlm.nih.gov/pubmed/34795409
http://dx.doi.org/10.1038/s41416-021-01623-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854436/
https://www.ncbi.nlm.nih.gov/pubmed/34795409
http://dx.doi.org/10.1038/s41416-021-01623-3

Ejemplares similares